Position in NVCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,725,000
-$4,063,250 QoQ
Shares Held
250,000
-52.4% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Vestal Point Capital, LP holds $201,095,221 across 8 Medical Devices names. NVCR ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMED |
Globus Medical Inc
|
610,520 | $52,602,403 | |
| 2 | BSX |
Boston Scientific Corp
|
800,000 | $50,200,000 | |
| 3 | INSP |
Inspire Medical Systems, Inc.
|
539,269 | $27,815,495 | |
| 4 | BBNX |
Beta Bionics, Inc.
|
2,211,518 | $22,159,410 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
250,000 | $17,795,000 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
190,000 | $17,179,800 | |
| 7 | PODD |
Insulet Corp
|
50,601 | $10,618,113 | |
| 8 | NVCR |
NovoCure Ltd
This page
|
250,000 | $2,725,000 |
All Filings in NVCR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,725,000 | 250,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,788,250 | 525,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,168,000 | 400,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||